Trial Profile
A Phase II Controlled Study of pegylated liposomal Doxorubicin (PLD, CAELYX) and Carboplatin for the Preoperative Treatment of Advanced Breast Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2012
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Carboplatin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms Cola
- 04 May 2012 New trial record